Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Elevated factor VII as a risk factor for recurrent fetal loss. Relationship to factor VII gene polymorphisms.

Miller CH, De Staercke C, Benson J, Hooper WC, Dilley A, Evatt BL, Benito C, Patterson-Barnett A, Eller D, Philipp CS.

Thromb Haemost. 2005 Jun;93(6):1089-94.

PMID:
15968393
2.

Polymorphisms of the coagulation factor VII gene and its plasma levels in relation to acute cerebral infarction differences in allelic frequencies between Chinese Han and European populations.

Kang WY, Wang HL, Xiong LF, Wang XF, Chu HY, Qu B, Liu XF, Yin J, Duan BH, Wang ZY.

Chin Med J (Engl). 2004 Jan;117(1):71-4.

PMID:
14733777
3.

[The connection between Arg353Gln polymorphism of coagulation factor VII and recurrent miscarriages].

Seremak-Mrozikiewicz A, Drews K, Kurzawińska G, Barlik M, Mrozikiewicz PM.

Ginekol Pol. 2009 Jan;80(1):8-13. Polish.

PMID:
19323053
4.

Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.

Lindman AS, Pedersen JI, Arnesen H, Hjerkinn EM, Veierød MB, Prydz H, Seljeflot I.

Thromb Res. 2004;113(1):57-65.

PMID:
15081566
5.

Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.

Moor E, Silveira A, van't Hooft F, Suontaka AM, Eriksson P, Blombäck M, Hamsten A.

Arterioscler Thromb Vasc Biol. 1995 May;15(5):655-64.

6.

Factor VII levels, R353Q and -323P0/10 Factor VII variants, and the risk of acute coronary syndrome among Arab-African Tunisians.

Ben-Hadj-Khalifa S, Lakhal B, Nsiri B, Mahjoub T, Almawi WY.

Mol Biol Rep. 2013 May;40(5):3793-8. doi: 10.1007/s11033-012-2456-4. Epub 2012 Dec 30.

PMID:
23275237
7.

Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations.

Bernardi F, Arcieri P, Bertina RM, Chiarotti F, Corral J, Pinotti M, Prydz H, Samama M, Sandset PM, Strom R, Garcia VV, Mariani G.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2548-53.

8.

Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis.

Bozzini C, Girelli D, Bernardi F, Ferraresi P, Olivieri O, Pinotti M, Martinelli N, Manzato F, Friso S, Villa G, Pizzolo F, Beltrame F, Corrocher R.

Thromb Haemost. 2004 Sep;92(3):541-9.

PMID:
15351850
9.

Plasma factor VII levels are influenced by a polymorphism in the promoter region of the FVII gene.

Sacchi E, Tagliabue L, Scoglio R, Baroncini C, Coppola R, Bernardi F, Mannucci PM.

Blood Coagul Fibrinolysis. 1996 Mar;7(2):114-7.

PMID:
8735799
10.

Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration.

van 't Hooft FM, Silveira A, Tornvall P, Iliadou A, Ehrenborg E, Eriksson P, Hamsten A.

Blood. 1999 May 15;93(10):3432-41. Erratum in: Blood 2000 Jul 1;96(1):8.

11.

Genotype associations of factor VII gene with plasma factor VII coagulant activity and antigen levels in healthy Chinese.

Liu Y, Heng CK, Saha N, Hong S, Low PS.

Blood Coagul Fibrinolysis. 2002 Apr;13(3):217-24.

PMID:
11943935
12.
13.

[Study on plasma coagulation factor VII (FVII) levels and polymorphisms of FVII gene in patients with coronary heart disease].

Kang W, Wang H, Xiong L, Wang X, Chu H, Qu B, Liu X, Yin J, Duan B, Yu J, Wang Z.

Zhonghua Xue Ye Xue Za Zhi. 2002 Sep;23(9):457-9. Chinese.

PMID:
12482354
14.

Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms.

Grimaudo S, Craxi A, Gentile S, Di Paolantonio T, Vaccaro A, Venezia G, Lo Coco L, Savella R, Usticano A, Capone F, Mariani G.

Dig Liver Dis. 2005 Jun;37(6):446-50. Epub 2005 Mar 16.

PMID:
15893284
15.

Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.

Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L.

Arterioscler Thromb Vasc Biol. 1996 Sep;16(9):1170-6.

17.

Modulation of factor VII levels by intron 7 polymorphisms: population and in vitro studies.

Pinotti M, Toso R, Girelli D, Bindini D, Ferraresi P, Papa ML, Corrocher R, Marchetti G, Bernardi F.

Blood. 2000 Jun 1;95(11):3423-8.

18.
19.

Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study.

Lane A, Green F, Scarabin PY, Nicaud V, Bara L, Humphries S, Evans A, Luc G, Cambou JP, Arveiler D, Cambien F.

Atherosclerosis. 1996 Jan 5;119(1):119-27.

PMID:
8929253
20.

Coagulation factor VII, serum-triglycerides and the R/Q353 polymorphism: differences between older men and women.

Mennen LI, de Maat MP, Schouten EG, Kluft C, de Jong PT, Hofman A, Grobbee DE.

Thromb Haemost. 1997 Sep;78(3):984-6.

PMID:
9308739

Supplemental Content

Support Center